Home > Insider Trading > Filing (0001455244-13-000011)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554591	Sukhi Jagpal	C/O Qlt Inc. 887 Great Northern Way, Suite 101 Vancouver A1 V5T 4T5	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-05-14	10,000	$7.12	11,200	No	4	M	Direct
Common Stock	Disposition	2013-05-14	9,900	$7.95	1,300	No	4	S	Direct
Common Stock	Disposition	2013-05-14	100	$7.96	1,200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (right to buy)	Disposition	2013-05-14	10,000	$0.00	10,000	$7.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-05-22	No	4	M	Direct

Footnotes

Price reflects the conversion of Canadian dollars to US dollars based on the noon exchange rate published by the Bank of Canada on the date of the reportable event which was 0.9854.
The option originally provided for vesting in 36 equal monthly installments measured from May 22, 2012. However, in connection with a change in control of the Company (as defined in the option agreement), the unvested shares under such option were accelerated and became fully exercisable on June 4, 2012.